10325-17-4 Usage
Uses
Used in Pharmaceutical Industry:
(D,L)-2-AMINO-HEPT-6-ENOIC ACID is used as a key intermediate in the synthesis of various pharmaceutical compounds for its role in the biosynthesis of natural products. Its unique structure and properties make it a valuable component in the development of new drugs and therapeutic agents.
Used in Biotechnology Industry:
In the biotechnology sector, (D,L)-2-AMINO-HEPT-6-ENOIC ACID is utilized as a building block for the production of bioactive compounds and secondary metabolites. Its presence in certain bacteria and fungi allows for its use in the engineering of microorganisms for the production of valuable bioproducts.
Used in Medicinal Applications:
(D,L)-2-AMINO-HEPT-6-ENOIC ACID is studied for its potential medicinal applications due to its involvement in the synthesis of secondary metabolites. Its unique properties and presence in natural sources make it a promising candidate for the development of new therapeutic agents and treatments.
Overall, (D,L)-2-AMINO-HEPT-6-ENOIC ACID is a versatile and important compound in various industries, particularly in the pharmaceutical and biotechnology sectors, due to its role in the biosynthesis of natural products and its potential for medicinal applications.
Check Digit Verification of cas no
The CAS Registry Mumber 10325-17-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,3,2 and 5 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 10325-17:
(7*1)+(6*0)+(5*3)+(4*2)+(3*5)+(2*1)+(1*7)=54
54 % 10 = 4
So 10325-17-4 is a valid CAS Registry Number.
10325-17-4Relevant academic research and scientific papers
A Biocatalytic Route to Enantiomerically Pure Unsaturated α-H-α-Amino Acids
Wolf, Larissa B.,Sonke, Theo,Tjen, Kim C. M. F.,Kaptein, Bernard,Broxterman, Quirinus B.,Schoemaker, Hans E.,Rutjes, Floris P. J. T.
, p. 662 - 674 (2007/10/03)
A set of both enantiomeric forms of non-proteinogenic, unsaturated α-H-α-amino acids was efficiently synthesized using a biocatalytic pathway. This route involved the straightforward synthesis of the required unsaturated amino acid amides, followed by resolution with an aminopeptidase present in Pseudomonas putida ATCC 12633 and/or a genetically modified organism, leading to the (S)-acids and (R)-amides. Undesired amino acid racemase activity was identified in the wild-type strain, which was absent in the newly developed organism. The (R)-amides were hydrolyzed under mild conditions using an amidase present in whole cells from Rhodococcus erythropolis NCIMB 11540 to the (R)-acids. The viability of this procedure was demonstrated with the multi-gram synthesis of a variety of unsaturated amino acids in excellent enantiopurity.
